Logo

UK Government Awards CellCentric $2M to Develop Epigenetic Cell-Based Screens

May 04, 2006

NEW YORK, May 4 (GenomeWeb News) - The UK's Department of Trade and Industry has awarded CellCentric £1.15 million ($2.1 million) to support development of cell-based screens for proteins and small molecules responsible for epigenetic changes, the company said today.

 

The DTI's Technology Program provided the funding as part of a £2.3 million, three-year program that also includes the Gurdon Institute and the Babraham Institute at the University of Cambridge and the University of Nottingham.

 

The epigenetic screens are expected to have applicability in bioprocessing, regenerative medicine, and cancer therapeutics, CellCentric said.

Breaking News
The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.